The link between allergic rhinitis and asthma: A role for antileukotrienes?

Canadian Respiratory Journal

Volumn 15, Issue 2, 2008, Pages 91-98

  Kim, H ^a,b   Bouchard, J ^c   Renzi, P M ^d,e  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ST JOSEPH S HOSPITAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e NONE   (Canada)

Author keywords

Antileukotrienes; Asthma; Epidemiology; Pathophysiology; Rhinitis

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CETIRIZINE; CORTICOSTEROID; DECONGESTIVE AGENT; GLUCOCORTICOID; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MOMETASONE FUROATE; MONOCLONAL ANTIBODY; MONTELUKAST; OMALIZUMAB; PLACEBO; PSEUDOEPHEDRINE; ZAFIRLUKAST;

ABSENCE OF SIDE EFFECTS; ABSENTEEISM; ADD ON THERAPY; ALLERGIC RHINITIS; ASTHMA; ATOPY; BEDTIME DOSAGE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TOLERABILITY; EVENING DOSAGE; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HOSPITAL CHARGE; HUMAN; IMMUNE RESPONSE; MEDICAL FEE; MONOTHERAPY; MORNING DOSAGE; NASAL PRURITUS; NOSE CONGESTION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT CARE; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHINORRHEA; SENSITIZATION; SLEEP; SNEEZING; SOCIAL ASPECT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 43549117496     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/416095     Document Type: Review

References (51)